Czech billionaire Michal Strnad has made an offer of roughly €30 billion to acquire Delfin, the Luxembourg-based holding company that controls the Del Vecchio family's vast investment empire, according to Reuters, citing people close to the matter. Delfin is best known as the largest shareholder in EssilorLuxottica, the eyewear giant behind Ray-Ban and Oakley, but its reach extends far beyond sunglasses and lenses.
The offer, first reported by Italian newspaper Il Domani, includes a letter dated October 20 from Tilaris, described as managing Strnad's non-defense interests, pitching Delfin as a long-term fit “at the top of the value chain.” Strnad, who built his fortune in the defense industry, is now looking to expand into a very different kind of portfolio.
What is Delfin and why does it matter?
Delfin is the personal investment vehicle of the late Leonardo Del Vecchio, the founder of Luxottica who died in 2022. It is now split equally among his eight heirs, including his widow and children from multiple marriages. The holding company owns significant stakes in some of Italy's most important financial institutions: insurer Assicurazioni Generali, and banks UniCredit and Monte dei Paschi di Siena, in addition to EssilorLuxottica. Combined, these listed stakes are worth roughly €43 billion at current market prices.
That makes Delfin one of the most powerful family holding companies in Europe, with influence over companies that touch millions of customers and investors. Any change in ownership could have ripple effects across European markets.
The challenge: getting eight heirs to agree
Reuters reports that a sale would require near-unanimous approval from the eight heirs, who have become increasingly divided in recent months. The family has already been grappling with governance issues, as heirs have sought to loosen Delfin's grip by changing voting rules, a move that itself highlighted internal tensions.
One heir, Leonardo Maria Del Vecchio, has already signaled resistance to the offer. He has said his father's life's work should remain part of Italy's heritage, a reminder that for many family owners, legacy and control can matter as much as price. The family has also shown a willingness to walk away from deals when conditions aren't right, as seen in the pause of a bid for Il Fatto Quotidiano after founders refused to sell.
Strnad's timing is tricky. Delfin's influence has grown, and the heirs may feel less pressure to sell. But a €30 billion offer is a substantial premium to what a private buyer might normally pay for a stake in a holding company, and it could tempt some heirs who prefer cash over continued involvement in complex governance battles.
What it means for investors
For everyday investors, this bid is a real-world example of what's known as a “holding-company discount.” Delfin's listed stakes are worth about €43 billion, yet Strnad is offering only €30 billion. That gap reflects the challenges of owning a portfolio of large, strategic stakes: they're hard to sell quickly without moving markets, and family governance adds an extra layer of risk.
If a deal were to go through, it could change the calculus for investors in EssilorLuxottica, Generali, UniCredit, and Monte dei Paschi. A new owner like Strnad might keep those stakes for the long term, or might eventually sell them down, creating what's known as a “blockholder overhang.” That uncertainty alone can affect share prices, as investors start pricing in the possibility of large block trades.
Even without a deal, the mere existence of a bid puts a price on Delfin's holdings and forces the heirs to confront a question they've been avoiding: is the family better off holding these assets or cashing out? The answer will shape the future of some of Europe's most iconic companies.
For now, investors should watch for any signs of movement among the heirs. A sale is far from certain, but the offer has already put Delfin's governance under a spotlight, and that could have lasting effects on the companies it controls.
